068760 — Celltrion Pharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Celltrion Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	20,940	34,579	25,960	21,265	21,966
Depreciation
Amortisation
Non-Cash Items	8,569	17,510	13,739	15,915	26,975
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-6,732	24,684	-61,163	-48,149	-12,446
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	36,246	93,151	-4,046	8,757	56,588
Capital Expenditures	-44,255	-12,501	-6,286	-6,898	-5,983
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-626	-3,803	-8,280	2,677	-6,133
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-44,880	-16,304	-14,566	-4,221	-12,116
Financing Cash Flow Items	-5,798	-5,642	-6,059	-8,278	-8,410
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	23,621	-22,410	-30,181	-16,215	-18,706
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	14,984	54,438	-48,795	-11,680	25,769